Abstract CT281: A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11
Abstract CT281: A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Abstract CT281: A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11 have?
Abstract CT281: A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11 has 0 citations in the OpenAlex counts ScholarIQ stores.
When was Abstract CT281: A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11 published?
Abstract CT281: A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11 has 2026 year in the ScholarIQ index.
What is the open-access status of Abstract CT281: A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11?
Abstract CT281: A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11 has closed oa status in the ScholarIQ index.
What is the DOI of Abstract CT281: A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11?
The DOI for Abstract CT281: A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11 is on the source record.
What is the OpenAlex record for Abstract CT281: A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11?
The OpenAlex for Abstract CT281: A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11 is on the source record.